NOT-AI-23-062: Notice of Early Expiration of "Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation", NOT-AI-22-072

Notice of Early Expiration of "Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation", NOT-AI-22-072

Notice Number:

NOT-AI-23-062

Key Dates

Release Date:

September 19, 2023

Related Announcements

September 19, 2023 - Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed). See NOFO PAR-23-297
September 19, 2023 - Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed). See NOFO PAR-23-296
October 6, 2022 - Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation. See NOSI NOT-AI-22-072

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform the extramural community that NOT-AI-22-072, “Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation” will be expired as of September 19, 2023

Applicants interested in the scientific topic can apply to PAR-23-297, Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed) and PAR-23-296, Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed).

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Brigitte Sanders, DVM, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3209
Email: [email protected]

Eric Lorenzo, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-443-4993
Email: [email protected]

Jeymohan Joseph, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 240-627-3869
Email: [email protected]